Overview
Cheng-yung Lin practices practicing medicine in Sanzhi, Taiwan.
Their clinical expertise encompasses Mucopolysaccharidoses (MPS), Secondary Parkinsonism, Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome).
They are actively involved in clinical research, co-authoring 28 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Cheng-yung Lin
Is Cheng-yung Lin a top-rated expert for Mucopolysaccharidoses (MPS)?
MediFind is an objective health platform that identifies experts based on real-world data. Cheng-yung Lin is classified as an Experienced expert for Mucopolysaccharidoses (MPS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Cheng-yung Lin participate in research or clinical trials?
Yes. Cheng-yung Lin has published 28 articles and abstracts on conditions like Mucopolysaccharidoses (MPS). You can view a list of Cheng-yung Lin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Aase SyndromeLin isExperienced. Learn about Aase Syndrome.
- Adenoid Cystic CarcinomaLin isExperienced. Learn about Adenoid Cystic Carcinoma.
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Mucopolysaccharidoses (MPS)
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- Neurotoxicity SyndromesLin isExperienced. Learn about Neurotoxicity Syndromes.
- Primary Lateral SclerosisLin isExperienced. Learn about Primary Lateral Sclerosis.
- Pure Red Cell AplasiaLin isExperienced. Learn about Pure Red Cell Aplasia.
- Secondary ParkinsonismLin isExperienced. Learn about Secondary Parkinsonism.